FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898181532> ?p ?o ?g. }

• W2898181532 endingPage "91" @default.
• W2898181532 startingPage "83" @default.
• W2898181532 abstract "Abstract EDITOR’S PERSPECTIVE What We Already Know about This Topic The incidence of major adverse cardiac events after electroconvulsive therapy is not known What This Article Tells Us That Is New Major adverse cardiac events and death after electroconvulsive therapy are infrequent and occur in about 1 of 50 patients and after about 1 of 200 to 500 electroconvulsive therapy treatments Background Cardiac events after electroconvulsive therapy have been reported sporadically, but a systematic assessment of the risk is missing. The goal of this study was to obtain a robust estimate of the incidence of major adverse cardiac events in adult patients undergoing electroconvulsive therapy. Methods Systematic review and meta-analysis of studies that investigated electroconvulsive therapy and reported major adverse cardiac events and/or mortality. Endpoints were incidence rates of major adverse cardiac events, including myocardial infarction, arrhythmia, pulmonary edema, pulmonary embolism, acute heart failure, and cardiac arrest. Additional endpoints were all-cause and cardiac mortality. The pooled estimated incidence rates and 95% CIs of individual major adverse cardiac events and mortality per 1,000 patients and per 1,000 electroconvulsive therapy treatments were calculated. Results After screening of 2,641 publications and full-text assessment of 284 studies, the data of 82 studies were extracted (total n = 106,569 patients; n = 786,995 electroconvulsive therapy treatments). The most commonly reported major adverse cardiac events were acute heart failure, arrhythmia, and acute pulmonary edema with an incidence (95% CI) of 24 (12.48 to 46.13), 25.83 (14.83 to 45.00), and 4.92 (0.85 to 28.60) per 1,000 patients or 2.44 (1.27 to 4.69), 4.66 (2.15 to 10.09), and 1.50 (0.71 to 3.14) per 1,000 electroconvulsive therapy treatments. All-cause mortality was 0.42 (0.11 to 1.52) deaths per 1,000 patients and 0.06 (0.02 to 0.23) deaths per 1,000 electroconvulsive therapy treatments. Cardiac death accounted for 29% (23 of 79) of deaths. Conclusions Major adverse cardiac events and death after electroconvulsive therapy are infrequent and occur in about 1 of 50 patients and after about 1 of 200 to 500 electroconvulsive therapy treatments." @default.
• W2898181532 created "2018-11-02" @default.
• W2898181532 creator A5007353369 @default.
• W2898181532 creator A5024082045 @default.
• W2898181532 creator A5038171309 @default.
• W2898181532 creator A5048625554 @default.
• W2898181532 creator A5075752885 @default.
• W2898181532 creator A5081181550 @default.
• W2898181532 date "2019-01-01" @default.
• W2898181532 modified "2023-10-16" @default.
• W2898181532 title "Major Adverse Cardiac Events and Mortality Associated with Electroconvulsive Therapy" @default.
• W2898181532 cites W1644329051 @default.
• W2898181532 cites W1966605677 @default.
• W2898181532 cites W1969728782 @default.
• W2898181532 cites W1977808412 @default.
• W2898181532 cites W1989202295 @default.
• W2898181532 cites W1998821464 @default.
• W2898181532 cites W2017198134 @default.
• W2898181532 cites W2058637146 @default.
• W2898181532 cites W2074950349 @default.
• W2898181532 cites W2091228321 @default.
• W2898181532 cites W2103891913 @default.
• W2898181532 cites W2111985824 @default.
• W2898181532 cites W2141838924 @default.
• W2898181532 cites W2147172602 @default.
• W2898181532 cites W2206889358 @default.
• W2898181532 cites W2317653829 @default.
• W2898181532 cites W2321873762 @default.
• W2898181532 cites W2415274481 @default.
• W2898181532 cites W2487222236 @default.
• W2898181532 cites W2586779306 @default.
• W2898181532 cites W2603819036 @default.
• W2898181532 cites W2754473234 @default.
• W2898181532 cites W4211039296 @default.
• W2898181532 cites W4251112759 @default.
• W2898181532 cites W4321068055 @default.
• W2898181532 doi "https://doi.org/10.1097/aln.0000000000002488" @default.
• W2898181532 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6300062" @default.
• W2898181532 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30557212" @default.
• W2898181532 hasPublicationYear "2019" @default.
• W2898181532 type Work @default.
• W2898181532 sameAs 2898181532 @default.
• W2898181532 citedByCount "36" @default.
• W2898181532 countsByYear W28981815322019 @default.
• W2898181532 countsByYear W28981815322020 @default.
• W2898181532 countsByYear W28981815322021 @default.
• W2898181532 countsByYear W28981815322022 @default.
• W2898181532 countsByYear W28981815322023 @default.
• W2898181532 crossrefType "journal-article" @default.
• W2898181532 hasAuthorship W2898181532A5007353369 @default.
• W2898181532 hasAuthorship W2898181532A5024082045 @default.
• W2898181532 hasAuthorship W2898181532A5038171309 @default.
• W2898181532 hasAuthorship W2898181532A5048625554 @default.
• W2898181532 hasAuthorship W2898181532A5075752885 @default.
• W2898181532 hasAuthorship W2898181532A5081181550 @default.
• W2898181532 hasBestOaLocation W28981815321 @default.
• W2898181532 hasConcept C120665830 @default.
• W2898181532 hasConcept C121332964 @default.
• W2898181532 hasConcept C126322002 @default.
• W2898181532 hasConcept C164705383 @default.
• W2898181532 hasConcept C197934379 @default.
• W2898181532 hasConcept C2776468924 @default.
• W2898181532 hasConcept C2777330709 @default.
• W2898181532 hasConcept C2777714996 @default.
• W2898181532 hasConcept C2778198053 @default.
• W2898181532 hasConcept C2910926394 @default.
• W2898181532 hasConcept C42219234 @default.
• W2898181532 hasConcept C500558357 @default.
• W2898181532 hasConcept C61511704 @default.
• W2898181532 hasConcept C71924100 @default.
• W2898181532 hasConceptScore W2898181532C120665830 @default.
• W2898181532 hasConceptScore W2898181532C121332964 @default.
• W2898181532 hasConceptScore W2898181532C126322002 @default.
• W2898181532 hasConceptScore W2898181532C164705383 @default.
• W2898181532 hasConceptScore W2898181532C197934379 @default.
• W2898181532 hasConceptScore W2898181532C2776468924 @default.
• W2898181532 hasConceptScore W2898181532C2777330709 @default.
• W2898181532 hasConceptScore W2898181532C2777714996 @default.
• W2898181532 hasConceptScore W2898181532C2778198053 @default.
• W2898181532 hasConceptScore W2898181532C2910926394 @default.
• W2898181532 hasConceptScore W2898181532C42219234 @default.
• W2898181532 hasConceptScore W2898181532C500558357 @default.
• W2898181532 hasConceptScore W2898181532C61511704 @default.
• W2898181532 hasConceptScore W2898181532C71924100 @default.
• W2898181532 hasIssue "1" @default.
• W2898181532 hasLocation W28981815321 @default.
• W2898181532 hasLocation W28981815322 @default.
• W2898181532 hasLocation W28981815323 @default.
• W2898181532 hasLocation W28981815324 @default.
• W2898181532 hasOpenAccess W2898181532 @default.
• W2898181532 hasPrimaryLocation W28981815321 @default.
• W2898181532 hasRelatedWork W1429622152 @default.
• W2898181532 hasRelatedWork W2296681196 @default.
• W2898181532 hasRelatedWork W2409310997 @default.
• W2898181532 hasRelatedWork W2892345094 @default.
• W2898181532 hasRelatedWork W2895939600 @default.
• W2898181532 hasRelatedWork W3115772308 @default.
• W2898181532 hasRelatedWork W4254147694 @default.

• next